Search

everythinglearnresearchcommunity

for

Search:↓

Certain medications can cause serious side effects, so it's important to report them.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Cyclophosphamide is preferred for severe cases in pediatric rheumatology and nephrology despite its side effects.

The PTH-CBD injection improved hair regrowth better than the daily ruxolitinib pill in mice.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Dapagliflozin improved blood sugar control in a man with Werner syndrome without side effects.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

The gel with apocynin-loaded nanoparticles shows promise for treating rheumatoid arthritis.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

A man with Acrodermatitis continua did not get better with etanercept treatment, and his condition worsened, suggesting treatment effectiveness may vary by genetics and race.

An antibiotic called co-trimoxazole can effectively treat autoimmune diseases.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Managing multiple autoimmune diseases in one patient is very challenging.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Abrocitinib may effectively treat stubborn alopecia universalis.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Intramuscular cyproterone acetate effectively treats hirsutism and improves skin conditions in women with hyperandrogenism.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Methotrexate is effective for treating rheumatoid arthritis but requires regular monitoring.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Using a higher concentration of triamcinolone acetonide leads to faster hair regrowth in scalp patchy alopecia areata.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.